These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8185369)

  • 1. High dose gammaglobulin treatment for atopic dermatitis.
    Kimata H
    Arch Dis Child; 1994 Apr; 70(4):335-6. PubMed ID: 8185369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case of atopic dermatitis concurrent with idiopathic thrombocytopenic purpura, whose serum thymus and activation-regulated chemokine level remained undetectable.
    Ozawa M; Sasahara Y; Aiba S
    J Dermatol; 2018 May; 45(5):606-608. PubMed ID: 29399856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased prevalence of atopic dermatitis in Kawasaki disease.
    Brosius CL; Newburger JW; Burns JC; Hojnowski-Diaz P; Zierler S; Leung DY
    Pediatr Infect Dis J; 1988 Dec; 7(12):863-6. PubMed ID: 3211629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose intravenous gamma-globulin treatment for hyperimmunoglobulinemia E syndrome.
    Kimata H
    J Allergy Clin Immunol; 1995 Mar; 95(3):771-4. PubMed ID: 7897163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin therapy for the treatment of severe atopic dermatitis.
    Lamb SR; Rademaker M
    Expert Opin Pharmacother; 2001 Jan; 2(1):67-74. PubMed ID: 11336569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks and benefits of intravenous immunoglobulin treatment in children.
    Fasano MB
    Curr Opin Pediatr; 1995 Dec; 7(6):688-94. PubMed ID: 8776020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of intravenous immunoglobulins in pediatric diseases.
    Ramasubramanian KV; Kumar A; Kabra SK; Seth V
    Indian Pediatr; 1999 Jan; 36(1):51-63. PubMed ID: 10709123
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous immune globulin use in children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1992 Jan; 146(2):121-4. PubMed ID: 1735037
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune supplementation and immune modulation with intravenous immunoglobulin.
    Mazer BD; Al-Tamemi S; Yu JW; Hamid Q
    J Allergy Clin Immunol; 2005 Oct; 116(4):941-4. PubMed ID: 16210080
    [No Abstract]   [Full Text] [Related]  

  • 10. [Is intravenous administration of immunoglobulins a first-choice method in autoimmune diseases?].
    Vermeulen M
    Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1955-8. PubMed ID: 8413702
    [No Abstract]   [Full Text] [Related]  

  • 11. [Reality and clinical application of immunoglobulin preparations].
    Miyara T; Saito A
    Nihon Naika Gakkai Zasshi; 1996 Jun; 85(6):824-8. PubMed ID: 8753046
    [No Abstract]   [Full Text] [Related]  

  • 12. [Polyvalent immunoglobins in general pediatrics: what place, what risk, and what cost?].
    Dommergues JP; Bader-Meunier B
    Arch Pediatr; 1999; 6 Suppl 2():397s-399s. PubMed ID: 10370548
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravenous immune globulin (i.v.IG) therapy in steroid-resistant atopic dermatitis.
    Noh G; Lee KY
    J Korean Med Sci; 1999 Feb; 14(1):63-8. PubMed ID: 10102526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of idiopathic thrombocytopenic purpura using a dose of immunoglobulin based on lean body mass.
    Woolfrey S; Dewar MS
    Ann Pharmacother; 1993 Apr; 27(4):510. PubMed ID: 8477131
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience with intravenous immunoglobulin in severe childhood atopic dermatitis.
    Ozen A; Baris S; Karakoc Aydiner E; Yucelten D; Nadir Bahceciler N
    Allergol Immunopathol (Madr); 2012; 40(2):131-3. PubMed ID: 21855202
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of high-dose intravenous immunoglobulin treatment for atopic dermatitis.
    Jolles S
    Clin Exp Dermatol; 2002 Jan; 27(1):3-7. PubMed ID: 11952659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VI nerve palsy after intravenous immunoglobulin in Kawasaki disease.
    Rodríguez-Lozano A; Juárez-Echenique JC; Rivas-Larrauri F; Gámez-González LB; Yamazaki-Nakashimada M
    Allergol Immunopathol (Madr); 2014; 42(1):82-3. PubMed ID: 23340202
    [No Abstract]   [Full Text] [Related]  

  • 18. Sensorineural hearing loss: an underdiagnosed complication of Kawasaki disease.
    Magalhães CM; Magalhães Alves NR; Oliveira KM; Silva IM; Gandolfi L; Pratesi R
    J Clin Rheumatol; 2010 Oct; 16(7):322-5. PubMed ID: 20859226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitis.
    Jolles S; Hughes J; Rustin M
    J Am Acad Dermatol; 1999 Jan; 40(1):121-3. PubMed ID: 9922029
    [No Abstract]   [Full Text] [Related]  

  • 20. High dose intravenous immunoglobulin in atopic dermatitis and hyper-IgE syndrome.
    Wakim M; Alazard M; Yajima A; Speights D; Saxon A; Stiehm ER
    Ann Allergy Asthma Immunol; 1998 Aug; 81(2):153-8. PubMed ID: 9723561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.